Ebele Ola
vice-presidentFemale0.0Global Dominance: 0.00%
Ebele Ola serves as the vice-president of clinical, medical, and regulatory affairs at Novo Nordisk Canada, where she emphasizes the ongoing commitment to the semaglutide molecule and its potential impact on healthcare.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Ebele Ola, Novo Nordisk Canada’s vice-president of clinical, medical and regulatory affairs, expressed commitment to the semaglutide molecule.
Canada will be a launching pad for the global race for generic OzempicThe Globe and Mail·
Canada· 2026-01-30
Canada· 2026-01-30
